Perhaps I don’t know enough but we are already know Pfizer etc have the proper distribution channels and production facilities in place.
Only two things are clear at this point. There’s still some doubt with the drug and until that’s addressed we won’t see consistent steady price appreciation. The other thing is MF probably won’t be successful going it alone with the fda according to many experts on this board since he isn’t big pharma.
Market Data 
Markets 
AI
